Drug Profile
Anti-VCAM monoclonal antibody 2A2
Alternative Names: 2A2; Anti-porcine VCAM monoclonal antibody 2A2; Monoclonal antibody 2A2Latest Information Update: 29 Jul 2021
Price :
$50
*
At a glance
- Originator Alexion Pharmaceuticals
- Class Monoclonal antibodies
- Mechanism of Action Vascular cell adhesion molecule inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Xenotransplant rejection
Most Recent Events
- 21 Jul 2021 Alexion Pharmaceuticals has been acquired by AstraZeneca and changed its name to Alexion AstraZeneca Rare Disease
- 14 Feb 1996 Preclinical development for Xenotransplant rejection in USA (Unknown route)